These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 39375989)

  • 1. The Awareness of and Adherence to the Pregnancy Prevention Program for Oral Retinoids: A Questionnaire Survey in Denmark.
    Backran D; Ahmad S; Hansen JM; Almarsdóttir AB; Jacobsen R
    Pharmacoepidemiol Drug Saf; 2024 Oct; 33(10):e70023. PubMed ID: 39375989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Awareness and Adherence of the Valproate Pregnancy Prevention Program: A Questionnaire Survey among Healthcare Professionals, Pharmacists, and Patients in Denmark.
    Oliveri NMB; Hansen JM; Almarsdóttir AB; Jacobsen R
    Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of compliance with isotretinoin PPP recommendations and exploration of reasons for non-compliance: Survey among French-speaking health care professionals and patients in Belgium.
    Lelubre M; Hamdani J; Senterre C; Amighi K; Peres M; Schneider MP; Bugnon O; De Vriese C
    Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):668-673. PubMed ID: 29726056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The implementation of risk minimization measures to prevent teratogenic pregnancy outcomes related to oral retinoid and valproate use in Belgium.
    Bertels X; Mehuys E; Boussery K; Lahousse L
    Acta Clin Belg; 2022 Oct; 77(5):815-822. PubMed ID: 34569444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Awareness, knowledge and practice of healthcare professionals following implementation of a Pregnancy Prevention Program for sodium valproate in Ireland: a multi-stakeholder cross-sectional study.
    Hughes JE; Buckley N; Looney Y; Kirwan G; Curran S; Doherty CP; Mullooly M; Bennett KE
    Expert Opin Drug Saf; 2021 Aug; 20(8):965-977. PubMed ID: 34080507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perception of drug teratogenicity among general practitioners and specialists in obstetrics/gynecology: a regional and national questionnaire-based survey.
    Gils C; Pottegård A; Ennis ZN; Damkier P
    BMC Pregnancy Childbirth; 2016 Aug; 16():226. PubMed ID: 27531162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supporting adherence to oral anticancer agents: clinical practice and clues to improve care provided by physicians, nurse practitioners, nurses and pharmacists.
    Timmers L; Boons CC; Verbrugghe M; van den Bemt BJ; Van Hecke A; Hugtenburg JG
    BMC Cancer; 2017 Feb; 17(1):122. PubMed ID: 28187759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study.
    Crijns I; Mantel-Teeuwisse A; Bloemberg R; Pinas E; Straus S; de Jong-van den Berg L
    Expert Opin Drug Saf; 2013 Jan; 12(1):29-38. PubMed ID: 23163396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoids and contraception.
    Ceyrac DL; Serfaty D; Lefrancq H
    Dermatology; 1992; 184(3):161-70. PubMed ID: 1392106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis.
    Durán CE; Riera-Arnau J; Abtahi S; Pajouheshnia R; Hoxhaj V; Gamba M; Alsina E; Martin-Perez M; Garcia-Poza P; Llorente-Garcia A; Gonzalez-Bermejo D; Ibánez L; Sabaté M; Vidal X; Ballarín E; Sanfélix-Gimeno G; Rodríguez-Bernal C; Peiró S; García-Sempere A; Sanchez-Saez F; Ientile V; Ingrasciotta Y; Guarneri C; Tanaglia M; Tari M; Herings R; Houben E; Swart-Polinder K; Holthuis E; Huerta C; Gini R; Roberto G; Bartolini C; Paoletti O; Limoncella G; Girardi A; Hyeraci G; Andersen M; Kristiansen SB; Hallgreen CE; Klungel O; Sturkenboom M
    Front Pharmacol; 2023; 14():1207976. PubMed ID: 37663263
    [No Abstract]   [Full Text] [Related]  

  • 11. Compliance with pregnancy prevention plan recommendations in 8672 French women of childbearing potential exposed to acitretin.
    Raguideau F; Mezzarobba M; Zureik M; Weill A; Ricordeau P; Alla F
    Pharmacoepidemiol Drug Saf; 2015 May; 24(5):526-33. PubMed ID: 25753265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription retinoid and contraception use in women in Australia: A population-based study.
    Gerhardy L; Nassar N; Litchfield M; Kennedy D; Smith A; Gillies MB; Pearson SA; Zoega H; Shand A
    Australas J Dermatol; 2024 Aug; 65(5):428-436. PubMed ID: 38693687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating awareness, knowledge and practice of healthcare professionals following implementation of a revised pregnancy prevention programme for isotretinoin in Ireland: A multi-stakeholder cross-sectional study.
    Hughes JE; Buckley N; Looney Y; Kirwan G; Mullooly M; Bennett KE
    Pharmacoepidemiol Drug Saf; 2023 Feb; 32(2):137-147. PubMed ID: 36073295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes, awareness, compliance and preferences among hormonal contraception users: a global, cross-sectional, self-administered, online survey.
    Hooper DJ
    Clin Drug Investig; 2010; 30(11):749-63. PubMed ID: 20818837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Risk Medication Prescriptions in Primary Care for Women Without Documented Contraception.
    Panchal BD; Cash R; Moreno C; Vrontos E; Bourne C; Palmer S; Simpson A; Panchal AR
    J Am Board Fam Med; 2019; 32(4):474-480. PubMed ID: 31300567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety Communication Tools and Healthcare Professionals' Awareness of Specific Drug Safety Issues in Europe: A Survey Study.
    de Vries ST; van der Sar MJM; Coleman AM; Escudero Y; Rodríguez Pascual A; Maciá Martínez MÁ; Cupelli A; Baldelli I; Šipić I; Andrić A; Michan L; Denig P; Mol PGM;
    Drug Saf; 2018 Jul; 41(7):713-724. PubMed ID: 29500798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Questionnaire survey about NSAIDs use in late pregnancy for pharmacists and physicians].
    Tanaka S; Asahina Y; Satoh H; Miki A; Hori S; Sawada Y
    Yakugaku Zasshi; 2014; 134(6):757-66. PubMed ID: 24882653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the availability of the teratogenic drug isotretinoin outside the pregnancy prevention programme: a survey of e-pharmacies.
    Lagan BM; Dolk H; White B; Uges DR; Sinclair M
    Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):411-8. PubMed ID: 24493556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral retinoids--efficacy and toxicity in psoriasis.
    Gollnick HP
    Br J Dermatol; 1996 Oct; 135 Suppl 49():6-17. PubMed ID: 9035704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor physician and pharmacist awareness of drug-related risks during pregnancy.
    Prescrire Int; 2007 Feb; 16(87):23. PubMed ID: 17323537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.